J.P. Morgan
234 articles with J.P. Morgan
-
Molecular Partners announced yesterday it has filed for a $100 million initial public offering with the Securities and Exchange Commission in the U.S., funding which will go toward supporting the company's work in the development of protein-based treatments for COVID-19 and various cancers.
-
The Medicines Company Announces Launch of Public Offering of Common Stock
6/24/2019
The Company expects to use the net proceeds of the offering to fund its development of inclisiran and for general corporate purposes.
-
Ahead of the JP Morgan Healthcare Conference, Jamie Dimon, chief executive officer of JP Morgan Chase, hosted a private dinner for biopharma executives Sunday night. Although the dinner was private, apparently one of the hot topics of discussion was a company not represented at the party—Amazon.
-
Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference
1/4/2019
Sangamo Therapeutics, Inc. announced that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco
-
Heska to Present at J.P. Morgan 2019 Healthcare Conference
1/4/2019
Heska Corporation announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the J.P. Morgan 2019 Healthcare Conference on Thursday, January 10, 2019 at 11 a.m. PT in San Francisco, CA.
-
Kenneth Frazier, chief executive officer of Merck, speaking with the Economic Club of New York, joined a growing list of pharmaceutical chiefs in criticizing the role of middlemen in rising drug prices.
-
Atul Gawande is heading out to hold one-on-one meetings with employees of a new healthcare venture to get a handle on their healthcare needs, challenges and concerns.
-
In January, Berkshire Hathaway, Amazon and JP Morgan Chase announced they were creating a joint healthcare venture. Today, they announced that Atul Gawande will be the chief executive officer.
-
Organizers said the media will be barred from the Q&A breakout sessions this year.
-
Biogen to Present at the 36th Annual J.P. Morgan Healthcare Conference
12/19/2017
To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors.
-
Incyte to Present at Upcoming Investor Conference
12/14/2017
Incyte Corporation announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.
-
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
1/16/2017
-
JPM17: Surprise! Pfizer is Still Deal Hungry for M&As After Medivation
1/16/2017
-
JPM17: Opko Health CEO's Gameplan After Its Recent Growth Hormone Failure
1/13/2017
-
JPM17: New Biogen CEO on Groundbreaking Alzheimer's Trial and the Company's Future
1/12/2017
-
JPM17: Kite Pharma's Strategy for Commercializing Its Lead CAR-T Drug
1/12/2017
-
JPM17: For Medtronic, Old Data Habits Die Hard
1/12/2017
-
JPM17: CureVac Release: Biotech's mRNA Program Fails Phase II Test, Putting Spotlight on Other Biotechs Like Moderna
1/12/2017
-
JPM17: Biotech IPO Guru Vivek Ramaswamy Expects More Startups, Deals in 2017
1/12/2017
-
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials
1/11/2017